Angiotech Pharmaceuticals, Inc.
U.S. FDA approves enhancements to Taxus stent system
Published in Drug Law Weekly, May 3rd, 2005
Angiotech Pharmaceuticals, Inc., (ANPI, ANP) corporate partner Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved enhancements to the Directions for Use (DFU) of the Taxus Express(2) paclitaxel-eluting coronary stent system, indicating that patients receiving the stent systems may safely undergo Magnetic Resonance Imaging (MRI) examination immediately following implantation.
The Taxus stent system is the first drug-eluting stent to receive approval for immediate post-procedure MRI. Boston Scientific's Express(2) (bare-metal) stent system also received approval for immediate MRI exams. Patients receiving coronary stents...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2005-05-03)
More Articles from Drug Law Weekly
- ARC Pharmaceuticals, Inc.
Pharmaceutical firm granted U.S. patent related to surgical adhesion therapy - Ark Therapeutics Group plc
License granted to Boehringer Ingelheim for access to technology - Biophan Technologies, Inc.
Biomedical device firm expands intellectual property portfolio - Dalton Pharma Services
Dalton Chemical Laboratories, Inc. announces name change - Healthcare Group Purchasing Industry Initiative
Healthcare group purchasing organizations promote business practices - Hollis-Eden Pharmaceuticals, Inc.
Phase I clinical study on NEUMUNE begins - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
